Delivery Order SPE2DB24D2205-SPE2DB24FDZML
Award Date
9/5/24
Potential Completion Date
9/6/24
Potential Value
$29K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to AmerisourceBergen Drug Corporation by the Defense Logistics Agency (DLA) for the supply of Menveo, a meningococcal vaccine. The contract is a firm fixed-price delivery order worth $89,381.65, with a period of performance ending on July 21, 2023. The contract was not set aside for any specific business category. AmerisourceBergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $16,084.50 firm fixed-price contract is for the supply of the Menveo vaccine, a meningococcal vaccine, with a completion date of September 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $64,490.00, is for the supply of 4,568,119,294 units of the Menveo vaccine, a meningococcal conjugate vaccine. The contract is a firm fixed-price delivery order, with a performance period ending on May 5, 2025. AmerisourceBergen, a for-profit organization headquartered in Conshohocken, Pennsylvania, is a significant supplier...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of the MENVEO vaccine. The $11,580.84 firm-fixed-price contract has an ultimate completion date of August 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical products and supplies to support various government healthcare programs. This delivery order is part of a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of pharmaceutical products. The specific item being delivered is described as "MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML", which is likely a meningococcal vaccine. The contract has a ceiling value of $5,979.30 and an ultimate completion date of August 7, 2024. This award is not associated with any set-aside program. AmerisourceBergen, a major pharmaceutical distributor,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,305.75, is for the delivery of Menveo, a meningococcal vaccine, with a completion date of November 6, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENVEO, a vaccine for the prevention of meningococcal disease. The contract has a ceiling value of $13,704.50 and a period of performance through July 30, 2024. It is a firm-fixed-price contract, and there is no set-aside designation. Amerisourcebergen, through its extensive supply chain network, will provide this critical vaccine...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of the MENVEO vaccine. The contract has a firm fixed price of $10,674.06 and a completion date of May 27, 2025. The award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,442.50, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. The award is not designated as a set-aside and has an ultimate completion date of July 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $158,462.40, is for the procurement of Menveo, a meningococcal conjugate vaccine, and has a period of performance through March 28, 2025. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger...